Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
LDLR- |
RCV000237766 | SCV000294749 | likely pathogenic | Hypercholesterolemia, familial, 1 | 2016-03-25 | criteria provided, single submitter | literature only | |
Color Diagnostics, |
RCV001186870 | SCV001353460 | likely pathogenic | Familial hypercholesterolemia | 2021-02-02 | criteria provided, single submitter | clinical testing | This missense variant (also known as p.Asp147Gly in the mature protein) replaces aspartic acid with glycine at codon 168 in LDLR type A repeat 4 of the ligand binding domain of the LDLR protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individuals affected with familial hypercholesterolemia (PMID: 20145306, 30592719; Color internal data). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Multiple different missense variants occurring at the same amino acid position (p.Asp168Asn, p.Asp168His) are known to be disease-causing (ClinVar variation ID: 183136, 251258), indicating that aspartic acid at this position is important for LDLR function. Based on available evidence, this variant is classified as Likely Pathogenic. |